Mashup Score:8
TCTMDPCI’s Role for Patients With HFrEF and Extensive CAD: Experts Debate - 5 days
Mashup Score:8
Twitter Feed: TCTMD
Mashup Score:5
TCTMDHigher Gradient After Tricuspid TEER Not Harmful at 1 Year: TriValve Registry - 5 days
Mashup Score:5
The study provides insight into “how far we should go in treating TR . . . and which gradients we should accept,” Andrea Scotti...
-
Higher Gradient After Tricuspid TEER Not Harmful at 1 Year: TriValve Registry https://t.co/cStQV9LfQ9 https://t.co/cStQV9LfQ9 - view on twitter
Specialty Menu Navigation COVID-19 Clinical Coronary Structural Endovascular...
-
Missing #THT2023? View slides and news now on TCTMD 📊📰🫀https://t.co/5FwlnFvv0w https://t.co/5FwlnFvv0w - view on twitter
More coverage:
#tht2023
Specialty Menu Navigation COVID-19 Clinical Coronary Structural Endovascular...
-
THT is in full swing up in Boston! Check out the latest on heart failure management, upcoming LVAD trials, hemodynamic monitoring, and the use of the lymphatic system in heart failure treatment. Don't miss any presentations from #THT2023 on TCTMD: https://t.co/x9fiXB8Oid https://t.co/x9fiXB8Oid - view on twitter
More coverage:
#tht2023
Mashup Score:3
TCTMDStudy Debunks Obesity Paradox in HF, Encourages BMI Alternatives - 2 days
Mashup Score:3
While good, the study doesn’t include needed information on physical activity and cardiorespiratory fitness, says Carl...
-
Study Debunks Obesity Paradox in HF, Encourages BMI Alternatives https://t.co/huwtXlRv1l https://t.co/huwtXlRv1l - view on twitter
Mashup Score:3
TCTMDPCI’s Role for Patients With HFrEF and Extensive CAD: Experts Debate - 2 days
Mashup Score:3
It’s clear the REVIVED-BCIS2 trial hasn’t put an end to PCI in this setting. But it should be used cautiously, Eric Velazquez...
-
For patients with HFrEF and CAD, what role does PCI play? Experts @dor_lotan, @ericvelazquezmd, and @JWMoses discuss the implications of REVIVED-BCIS2 and GDMT versus PCI. Don't miss our top story from #THT2023 from @ToddNeale: https://t.co/9Rnzv7bKs7 https://t.co/9Rnzv7bKs7 - view on twitter
More coverage:
#tht2023
Mashup Score:2
TCTMDTEER or VAD/Transplant in the Advanced HF Patient With MR? - 5 days
Mashup Score:2
In a THT 2023 debate, a 57-year-old with severe HF was the jumping off point for discussing what’s gained or lost with...
-
TEER or VAD/Transplant in the Advanced HF Patient With MR? https://t.co/RxUrfEX68p https://t.co/RxUrfEX68p - view on twitter
Mashup Score:1
TCTMDMarch 2023 News Roundup - 3 days
Mashup Score:1
This month features road noise dangers, a revascularization odyssey, ChatGPT does discharge summaries, and...
-
March 2023 News Roundup https://t.co/n90B5ivsvb https://t.co/n90B5ivsvb - view on twitter
Mashup Score:1
TCTMDPromising Preliminary Results for AccuCinch LV Restoration System in HFrEF - 5 days
Mashup Score:1
The main question to be addressed by the ongoing pivotal CORCINCH-HF trial is what this adds versus optimal GDMT...
-
Promising Preliminary Results for AccuCinch LV Restoration System in HFrEF https://t.co/9Td5s1efc6 https://t.co/9Td5s1efc6 - view on twitter
Mashup Score:1
TCTMDPregnancy Health, Mortality Link Especially Pronounced in Black Women - 1 week
Mashup Score:1
Over 50 years of data cement the association between pregnancy complications and premature death, but solutions remain...
-
Pregnancy Health, Mortality Link Especially Pronounced in Black Women https://t.co/qOgeaHxyZV - view on twitter
It’s clear the REVIVED-BCIS2 trial hasn’t put an end to PCI in this setting. But it should be used cautiously, Eric Velazquez...
PCI’s Role for Patients With HFrEF and Extensive CAD: Experts Debate https://t.co/SNeOL7CzDy https://t.co/SNeOL7CzDy - view on twitter